The recall was officially announced on August 27, 2025
Retatrutide is under active investigation for its potential roles in metabolic regulation , energy expenditure, glucose balance, and multi-receptor hormone activity
Consistent with our results, using liver-specific knockdown of DPP4 via therapeutic siRNA, in obese and diabetic db/db mice, no effect on liver enzymes or glucose tolerance is observed (23)
Up to 24% body weight reduction in Phase 2 trials
24 Overweight and Obesity Treatment Weight loss is a key factor in the prevention and control of coronary heart disease, hyperlipidemia, hypertension, inflammation, insulin resistance, type 2 diabetes, cardiorespiratory failure, and a 5% weight loss can reduce, eliminate, or prevent these and many other medical conditions
This is achieved through the blends influence on natural GH pulses, which are essential for muscle gain and the maintenance of healthy body composition